Free Trial

Semler Scientific (SMLR) Competitors

Semler Scientific logo
$28.20 -0.16 (-0.56%)
Closing price 04:00 PM Eastern
Extended Trading
$28.54 +0.35 (+1.22%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SMLR vs. CDRE, NVCR, CNMD, KMTS, PLSE, BLFS, ESTA, SSII, MDXG, and INMD

Should you be buying Semler Scientific stock or one of its competitors? The main competitors of Semler Scientific include Cadre (CDRE), NovoCure (NVCR), CONMED (CNMD), Kestra Medical Technologies (KMTS), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), Establishment Labs (ESTA), SS Innovations International (SSII), MiMedx Group (MDXG), and InMode (INMD). These companies are all part of the "medical equipment" industry.

Semler Scientific vs. Its Competitors

Cadre (NYSE:CDRE) and Semler Scientific (NASDAQ:SMLR) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership.

Semler Scientific has lower revenue, but higher earnings than Cadre. Semler Scientific is trading at a lower price-to-earnings ratio than Cadre, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cadre$567.56M2.76$36.13M$0.9441.04
Semler Scientific$56.29M7.42$40.90M$2.4311.60

Cadre currently has a consensus target price of $31.50, suggesting a potential downside of 18.35%. Semler Scientific has a consensus target price of $74.25, suggesting a potential upside of 163.30%. Given Semler Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Semler Scientific is more favorable than Cadre.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cadre
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Semler Scientific
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

Cadre has a beta of 1.34, indicating that its stock price is 34% more volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500.

44.0% of Cadre shares are held by institutional investors. Comparatively, 49.4% of Semler Scientific shares are held by institutional investors. 31.5% of Cadre shares are held by company insiders. Comparatively, 16.4% of Semler Scientific shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Semler Scientific had 22 more articles in the media than Cadre. MarketBeat recorded 25 mentions for Semler Scientific and 3 mentions for Cadre. Semler Scientific's average media sentiment score of 0.14 beat Cadre's score of -0.08 indicating that Semler Scientific is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cadre
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Semler Scientific
1 Very Positive mention(s)
2 Positive mention(s)
20 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Semler Scientific has a net margin of 86.20% compared to Cadre's net margin of 6.65%. Semler Scientific's return on equity of 43.84% beat Cadre's return on equity.

Company Net Margins Return on Equity Return on Assets
Cadre6.65% 12.08% 5.60%
Semler Scientific 86.20%43.84%32.88%

Summary

Semler Scientific beats Cadre on 13 of the 16 factors compared between the two stocks.

Get Semler Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMLR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SMLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMLR vs. The Competition

MetricSemler ScientificMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$417.64M$6.97B$6.10B$10.65B
Dividend YieldN/A1.15%5.70%4.74%
P/E Ratio11.6027.6685.5527.59
Price / Sales7.42198.81621.78138.47
Price / Cash6.8722.0037.7861.77
Price / Book1.135.4513.136.76
Net Income$40.90M$178.04M$3.30B$275.88M
7 Day Performance-9.12%5.08%5.29%3.72%
1 Month Performance-0.32%12.65%9.94%10.22%
1 Year Performance10.07%35.38%87.78%35.86%

Semler Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMLR
Semler Scientific
3.3124 of 5 stars
$28.20
-0.6%
$74.25
+163.3%
+11.8%$417.64M$56.29M11.60120Analyst Forecast
Gap Up
CDRE
Cadre
2.2113 of 5 stars
$36.06
-0.8%
$31.50
-12.6%
-3.2%$1.48B$567.56M38.362,284Analyst Forecast
NVCR
NovoCure
4.2369 of 5 stars
$12.92
+0.2%
$28.79
+122.8%
-3.1%$1.44B$605.22M-8.281,488Analyst Forecast
CNMD
CONMED
4.6314 of 5 stars
$45.64
-0.8%
$59.80
+31.0%
-28.3%$1.42B$1.31B12.933,900Analyst Forecast
KMTS
Kestra Medical Technologies
1.1509 of 5 stars
$23.41
-3.8%
$27.33
+16.8%
N/A$1.25B$66.40M0.00300Analyst Forecast
PLSE
Pulse Biosciences
3.2351 of 5 stars
$17.80
+0.2%
$22.00
+23.6%
+22.6%$1.20B$700K-16.95140News Coverage
Analyst Forecast
BLFS
BioLife Solutions
2.1406 of 5 stars
$24.52
-0.7%
$31.29
+27.6%
+9.8%$1.18B$93.47M-204.32440News Coverage
Positive News
Analyst Forecast
ESTA
Establishment Labs
2.8457 of 5 stars
$41.37
+5.8%
$56.50
+36.6%
-12.5%$1.13B$166.02M-13.561,018Positive News
Analyst Forecast
SSII
SS Innovations International
N/A$5.65
+1.6%
N/AN/A$1.08B$20.65M0.004Analyst Forecast
MDXG
MiMedx Group
3.4211 of 5 stars
$6.93
-0.1%
$12.00
+73.2%
+29.4%$1.03B$348.88M33.00870Positive News
Analyst Forecast
INMD
InMode
3.1713 of 5 stars
$15.00
+0.7%
$18.04
+20.3%
-0.5%$941.81M$401.56M6.07480Positive News
Analyst Forecast

Related Companies and Tools


This page (NASDAQ:SMLR) was last updated on 10/8/2025 by MarketBeat.com Staff
From Our Partners